Glassia (alpha1-proteinase inhibitor (Human)) / Takeda 
Welcome,         Profile    Billing    Logout  
 0 Diseases   2 Trials   2 Trials   86 News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Glassia (alpha1-proteinase inhibitor (Human)) / Takeda
NCT02464878: Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

Completed
2
2
US
Alpha 1-Antitrypsin, Glassia, Islet Transplantation, Thymoglobulin, Antithymocyte Globulin, Basiliximab, Etanercept, Enbrel
Massachusetts General Hospital, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Iowa
Kidney Transplant, Type 1 Diabetes
11/22
12/22
NCT03172455: Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

No Longer Available
N/A
NA
Glassia, Alpha 1 antitrypsin
Impatients N.V. trading as myTomorrows, Kamada, Ltd.
Acute-graft-versus-host Disease, Steroid Refractory Acute Graft Versus Host Disease, Graft-versus-host-disease, Graft Vs Host Disease, Alpha 1-Antitrypsin Deficiency, Alpha-1 Proteinase Inhibitor, Alpha-1 Protease Inhibitor Deficiency, Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant
 
 

Download Options